Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

SciClone and Sigma-Tau sign Zadaxin partnership

April 19, 1999

COX-2 inhibitors can potentially be used safely in patients with decompensated cirrhosis

April 19, 1999

Low-dose IL-2 provides benefits in treatment-refractory HCV patients

April 16, 1999

Data on adefovir dipivoxil against HBV presented at EASL conference

April 16, 1999

Neurokinin antagonists for IBS synthesized and evaluated at Solvay

April 15, 1999

FDA requires further info about Hepagene vaccine

April 15, 1999

Colazide receives pricing approval in Sweden

April 14, 1999

Korea research institute describes new compounds with reversible antisecretory activity

April 12, 1999

Preclinical results indicate potential value of clevudine in chronic HBV infections

April 9, 1999

Neurokinin antagonists from Solvay particularly useful for GI disorders

April 9, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...